SEELQ Financials: Seelos Therapeutics Inc AI Analysis



Financials

SEELQ Financial

Seelos Therapeutics Inc

At close: Aug 07, 16:00:00 GMT-4

Post-market: Aug 07, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0001

Open

$0.0001

Day's Range

$0.0001 - $0.0001

52 week range

$0 - $0.01

Volume

100

Avg.Volume

2.1K

Dividend yield

EPS (TTM)

19.96

Market Cap

$44

What is SEELQ?

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 8 full-time employees. The company has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.

Features

Markets

News

Breakdown	TTM	06/30/2024	03/31/2024	12/31/2023	09/30/2023	06/30/2023
Revenue	2	0	0	0	0	0
Revenue Growth (YoY)	100%	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	2	3	2	2	2
Research & Development	20	0	3	5	10	8
Operating Expenses	31	3	6	8	13	11
Other Non Operating Income (Expenses)	39	4	4	2	26	-13
Pretax Income	4	1	-2	-5	10	-29
Income Tax Expense	--	--	--	--	--	--
Net Income	4	1	-2	-5	10	-29
Net Income Growth	-105%	-103%	-85%	-72%	-153%	38%
Shares Outstanding (Diluted)	0.15	0.15	1.62	0.86	0.61	0.54
Shares Change (YoY)	-71%	-71%	247%	94%	39%	24%
EPS (Diluted)	26.02	10.87	-1.64	-6.29	17.01	-53.67
EPS Growth	-118%	-120%	-94%	-85%	-139%	11%
Free Cash Flow	-13	0	-4	-1	-5	-5
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-1,450%	0%	0%	0%	0%	0%
Profit Margin	200%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-650%	0%	0%	0%	0%	0%
EBITDA	-29	-3	--	--	--	--
EBITDA Margin	-1,450%	0%	--	--	--	--
D&A For EBITDA	0	0	--	--	--	--
EBIT	-29	-3	-6	-8	-12	-10
EBIT Margin	-1,450%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Breakdown

TTM

06/30/2024

03/31/2024

12/31/2023

09/30/2023

06/30/2023

Revenue

Revenue Growth (YoY)

100%

Cost of Revenue

Gross Profit

Selling, General & Admin

Research & Development

Operating Expenses

Other Non Operating Income (Expenses)

-13

Pretax Income

-2

-5

-29

Income Tax Expense

Net Income

-2

-5

-29

Net Income Growth

-105%

-103%

-85%

-72%

-153%

38%

Shares Outstanding (Diluted)

0.15

1.62

0.86

0.61

0.54

Shares Change (YoY)

-71%

247%

94%

39%

24%

EPS (Diluted)

26.02

10.87

-1.64

-6.29

17.01

-53.67

EPS Growth

-118%

-120%

-94%

-85%

-139%

11%

Free Cash Flow

-13

-4

-1

-5

Free Cash Flow Per Share

Gross Margin

Operating Margin

-1,450%

Profit Margin

200%

Free Cash Flow Margin

-650%

EBITDA

-29

-3

EBITDA Margin

-1,450%

D&A For EBITDA

EBIT

-29

-3

-6

-8

-12

-10

EBIT Margin

-1,450%

Effective Tax Rate

Follow-Up Questions

What are Seelos Therapeutics Inc's key financial statements?



According to the latest financial statement (Form-10K), Seelos Therapeutics Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for SEELQ?



Seelos Therapeutics Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Seelos Therapeutics Inc's revenue broken down by segment or geography?



Seelos Therapeutics Inc largest revenue segment is Pharmaceutical Products, at a revenue of 2,203,000 in the most earnings release.For geography, United States is the primary market for Seelos Therapeutics Inc, at a revenue of 2,203,000.

Is Seelos Therapeutics Inc profitable?



no, according to the latest financial statements, Seelos Therapeutics Inc has a net loss of $0

Does Seelos Therapeutics Inc have any liabilities?



no, Seelos Therapeutics Inc has liability of 0

How many outstanding shares for Seelos Therapeutics Inc?



Seelos Therapeutics Inc has a total outstanding shares of 0

Seelos Therapeutics Inc (SEELQ) Financial

SEELQ Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is SEELQ?

Seelos Therapeutics Inc (SEELQ) Financial

SEELQ Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is SEELQ?

SEELQ Income

Follow-Up Questions

What are Seelos Therapeutics Inc's key financial statements?

What are the key financial ratios for SEELQ?

How is Seelos Therapeutics Inc's revenue broken down by segment or geography?

Is Seelos Therapeutics Inc profitable?

Does Seelos Therapeutics Inc have any liabilities?

How many outstanding shares for Seelos Therapeutics Inc?